http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010222637-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_279753329e9e55653159266d71a9dd5b
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-1081
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2210-0693
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-1095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-0002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4064
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2025-0681
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-026
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-02152
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-6853
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-172
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3613
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3621
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M25-1011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-02158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4076
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-958
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-362
filingDate 2010-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_025c3ea90f56bfb7d800c648214040ce
publicationDate 2010-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2010222637-A1
titleOfInvention Systems and methods for selective auto-retroperfusion of the cerebral venous system
abstract Methods for delivering a bridge retroperfusion therapy are disclosed such that, after the onset of a stroke or other adverse cerebral event, the brain cells' window of viability may be extended and other treatments, including pharmaceutical and neuroprotective therapies, may be more effectively utilized. Kits comprising devices and systems for delivering such retroperfusion and autoretroperfusion methods are also disclosed. In certain embodiments, the kits comprise a catheter and a flow unit configured to adjust the flow rate and pressure of the arterial blood used for perfusion of the venous system.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014039537-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105343985-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11298038-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11771558-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113261937-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10328244-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11135077-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10702387-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016158506-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017053398-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10434289-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017273791-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022181126-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013128013-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9561035-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106730073-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013172782-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016166807-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015059217-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017031235-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10314541-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018168838-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10780252-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106621001-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10786660-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10737072-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10792473-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11413434-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102319474-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11464948-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3337409-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016533802-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11123482-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017312483-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018187506-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013317535-A1
priorityDate 2009-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002077581-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5794629-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006047262-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394110
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395300
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91670

Total number of triples: 75.